Search for Clinical Trial Results

Sponsored By

Optic Pathway Glioma - 25 Studies Found

Status Study
Completed Study Name: Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
Condition: Visual Pathway Glioma
Date: 1999-11-01
Interventions: Drug: Antineoplaston therapy (Atengenal + Astugenal) Children with a visual pathway glioma, which is not
Recruiting Study Name: Phase II Pegylated Interferon
Condition:
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
    • Date: 2015-01-08
    Interventions: Drug: Pegylated interferon alpha-2b PEG-Intron 1mcg/kg/dose weekly through an injection under the skin o
Active, not recruiting Study Name: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
Condition:
  • Neurofibromatosis Type 1
  • Recurrent Childhood Pilocytic Astrocytoma
  • Drug: Lenalidomide Given PO
Active, not recruiting Study Name: Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.
Condition: Neurofibromatosis Type 1
Date: 2014-02-26
Withdrawn Study Name: Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Condition: Optic Nerve Glioma
Date: 2010-12-13
Interventions:
  • Drug: Temozolomide Study subje
Terminated Study Name: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas
Condition:
  • neurofibromatosis1 (NF1)
  • Recurrent or Progressive Optic Pathway Glioma
    Date: 2011-04-18
    Interventions: Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will
Recruiting Study Name: Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
Condition: Neurofibromatosis Type 1
Date: 2015-10-20
Interventions:
  • Device: Magnetic resonance imaging

Recruiting Study Name: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Condition:
  • Glioma
  • Neurofibromatosis Type 1
  • Recurrent Childhood Pilocy
    Date: 2010-03-17
    Interventions:
    • Other: Laboratory Biomarker Analysis

Active, not recruiting Study Name: Pomalidomide in Treating Younger Patients With Recurrent, Progressive or Refractory Central Nervous System Tumors
Condition:
  • Neurofibromatosis Type 1
  • Recurrent Central Nervous System Neoplasm
  • Other: Laboratory Biomarker Analysis

Withdrawn Study Name: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Condition:
  • Acoustic Schwannoma
  • Adult Anaplastic Astrocytoma
  • Adult Ana
    Date: 2014-07-16
    Interventions:
    • Radiation: gallium Ga 68-edotreotide

Next >>>